The authors' response: Propofol and sedation in patients with coronavirus disease 2019.

Soh, Mitsuhito; Hifumi, Toru; Isokawa, Shutaro; Shimizu, Masato; Otani, Norio; Ishimatsu, Shinichi

Soh, Mitsuhito; Hifumi, Toru; Isokawa, Shutaro; Shimizu, Masato; Otani, Norio; Ishimatsu, Shinichi.

Afiliação

Soh M; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.
Hifumi T; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan. Electronic address: hifumitoru@gmail.com.
Isokawa S; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.
Shimizu M; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.
Otani N; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.
Ishimatsu S; Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.

Am J Emerg Med ; 42: 251, 2021 Apr.

Article em En | MEDLINE | ID: mdl-32611498

Assuntos

COVID-19; Coronavirus; Propofol; Sedação Consciente; Humanos; Hipnóticos e Sedativos; SARS-CoV-2

Palavras-chave

COVID-19; Neuroleptic malignant syndrome; propofol

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propofol / Coronavirus / COVID-19 Limite: Humans Idioma: En Revista: Am J Emerg Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google